Literature DB >> 16288912

SVA elements: a hominid-specific retroposon family.

Hui Wang1, Jinchuan Xing, Deepak Grover, Dale J Hedges, Kyudong Han, Jerilyn A Walker, Mark A Batzer.   

Abstract

SVA is a composite repetitive element named after its main components, SINE, VNTR and Alu. We have identified 2762 SVA elements from the human genome draft sequence. Genomic distribution analysis indicates that the SVA elements are enriched in G+C-rich regions but have no preferences for inter- or intragenic regions. A phylogenetic analysis of the elements resulted in the recovery of six subfamilies that were named SVA_A to SVA_F. The composition, age and genomic distribution of the subfamilies have been examined. Subfamily age estimates based upon nucleotide divergence indicate that the expansion of four SVA subfamilies (SVA_A, SVA_B, SVA_C and SVA_D) began before the divergence of human, chimpanzee and gorilla, while subfamilies SVA_E and SVA_F are restricted to the human lineage. A survey of human genomic diversity associated with SVA_E and SVA_F subfamily members showed insertion polymorphism frequencies of 37.5% and 27.6%, respectively. In addition, we examined the amplification dynamics of SVA elements throughout the primate order and traced their origin back to the beginnings of hominid primate evolution, approximately 18 to 25 million years ago. This makes SVA elements the youngest family of retroposons in the primate order.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288912     DOI: 10.1016/j.jmb.2005.09.085

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  160 in total

1.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

Review 2.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

3.  Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution.

Authors:  Shai Carmi; George M Church; Erez Y Levanon
Journal:  Nat Commun       Date:  2011-11-01       Impact factor: 14.919

4.  Characterization of pre-insertion loci of de novo L1 insertions.

Authors:  Stephen L Gasior; Graeme Preston; Dale J Hedges; Nicolas Gilbert; John V Moran; Prescott L Deininger
Journal:  Gene       Date:  2006-09-12       Impact factor: 3.688

Review 5.  Transposable elements as drivers of genomic and biological diversity in vertebrates.

Authors:  Astrid Böhne; Frédéric Brunet; Delphine Galiana-Arnoux; Christina Schultheis; Jean-Nicolas Volff
Journal:  Chromosome Res       Date:  2008       Impact factor: 5.239

6.  Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase.

Authors:  José L Garcia-Perez; Aurélien J Doucet; Alain Bucheton; John V Moran; Nicolas Gilbert
Journal:  Genome Res       Date:  2007-04-06       Impact factor: 9.043

7.  Enrichment of processed pseudogene transcripts in L1-ribonucleoprotein particles.

Authors:  Prabhat K Mandal; Adam D Ewing; Dustin C Hancks; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2013-05-21       Impact factor: 6.150

Review 8.  Retroelements and their impact on genome evolution and functioning.

Authors:  Elena Gogvadze; Anton Buzdin
Journal:  Cell Mol Life Sci       Date:  2009-08-02       Impact factor: 9.261

9.  5'-Transducing SVA retrotransposon groups spread efficiently throughout the human genome.

Authors:  Annette Damert; Julija Raiz; Axel V Horn; Johannes Löwer; Hui Wang; Jinchuan Xing; Mark A Batzer; Roswitha Löwer; Gerald G Schumann
Journal:  Genome Res       Date:  2009-08-03       Impact factor: 9.043

Review 10.  Explaining human uniqueness: genome interactions with environment, behaviour and culture.

Authors:  Ajit Varki; Daniel H Geschwind; Evan E Eichler
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.